Breaking News, Promotions & Moves

Hovione Names Dr. Jean-Luc Herbeaux as CEO

Herbeaux succeeds Guy Villax, who will now serve as a member of the Board and shareholder.

Author Image

By: Charlie Sternberg

Associate Editor

Hovione’s Board of Directors and shareholders have approved the appointment of Dr. Jean-Luc Herbeaux as Hovione’s chief executive officer, effective April 1, 2022.   Guy Villax, who has been Hovione’s CEO for the past 25 years will now serve as a Member of the Board and shareholder. During his tenure, Hovione grew tenfold.   “It has been a privilege and honor to lead Hovione over the last decades. Hovione is a great company because of its people and its clients. It has been an amazing entrep...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters